Found: 24
Select item for more details and to access through your institution.
Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Neoadjuvant Vinorelbine—Capecitabine Versus Docetaxel-Doxorubicin-Cyclophosphamide in Early Nonresponsive Breast Cancer: Phase Ill Randomized GeparTrio Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 8, p. 542, doi. 10.1093/jnci/djn085
- By:
- Publication type:
- Article
Intensified Neoadjuvant Chemotherapy in Early-Responding Breast Cancer: Phase Ill Randomized GeparTrio Study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 8, p. 552, doi. 10.1093/jnci/djn089
- By:
- Publication type:
- Article
HER-2/neu Gene Amplification and Response to Paclitaxel in Patients With Metastatic Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2004, v. 96, n. 15, p. 1141, doi. 10.1093/jnci/djh198
- By:
- Publication type:
- Article
Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 152, n. 2, p. 377, doi. 10.1007/s10549-015-3479-z
- By:
- Publication type:
- Article
Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 150, n. 1, p. 127, doi. 10.1007/s10549-015-3287-5
- By:
- Publication type:
- Article
Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 144, n. 1, p. 153, doi. 10.1007/s10549-014-2861-6
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1862, doi. 10.2967/jnumed.112.119271
- By:
- Publication type:
- Article
Adjuvant Therapy With Zoledronic Acid in Patients With Breast Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Adjuvant Therapy With Zoledronic Acid in Patients With Breast Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Oncologist, 2013, v. 18, n. 4, p. 353, doi. 10.1634/theoncologist.2012-0261
- By:
- Publication type:
- Article
A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Effective Inhibition of Aromatase Inhibitor-associated Bone Loss by Zoledronic Acid in Postmenopausal Women With Early Breast Cancer Receiving Adjuvant Letrozole.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 5, p. 1001, doi. 10.1002/cncr.23259
- By:
- Publication type:
- Article
Surgical Outcome after Neoadjuvant Chemotherapy and Bevacizumab: Results from the GeparQuinto Study (GBG 44).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 8, p. 2517, doi. 10.1245/s10434-014-3606-9
- By:
- Publication type:
- Article
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-546
- By:
- Publication type:
- Article
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 546, doi. 10.1186/1471-2407-14-546
- By:
- Publication type:
- Article
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 139, n. 3, p. 779, doi. 10.1007/s10549-013-2589-8
- By:
- Publication type:
- Article
Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer-results from the GeparQuattro study (GBG 40).
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 132, n. 3, p. 863, doi. 10.1007/s10549-011-1621-0
- By:
- Publication type:
- Article
Overexpression of p53 and prognosis in breast cancer.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III Gepar Quinto study.
- Published in:
- International Journal of Cancer, 2015, v. 137, n. 12, p. 2981, doi. 10.1002/ijc.29656
- By:
- Publication type:
- Article
Sorafenib in the Treatment of Early Breast Cancer: Results of the Neoadjuvant Phase II Study - SOFIA*.
- Published in:
- Breast Care, 2014, v. 9, n. 3, p. 169, doi. 10.1159/000363430
- By:
- Publication type:
- Article
Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Sorafenib in the Treatment of Early Breast Cancer: Results of the Neoadjuvant Phase II Study - SOFIA*.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article